Why some patients may develop severe intestinal inflammation after CAR-T therapy
Researchers at the Icahn School of Medicine at Mount Sinai have identified biological mechanisms that may contribute to CAR-T cell-associated enterocolitis, a serious inflammatory condition of the intestine that can occur after a type of CAR-T cell therapy for multiple myeloma.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Cystic fibrosis: Triple therapy is particularly effective in early childhood
United Kingdom
-
Virtual reality and classical music help to reduce blood pressure in patients in emergency department
United Kingdom
-
Drones could speed up delivery of automated external defibrillators to patients suffering cardiac arrest
United Kingdom
-
Steatotic liver disease risk scores compared for predicting cirrhosis
United Kingdom
-
Tapping the power of cryo-ET to visualize how molecular machines interact inside cells
United Kingdom
-
UC researcher receives funding to study bone complications in people with sickle cell disease
United Kingdom
-
Aga's restaurant in Houston is number one in the world for Uber Eats deliveries
United States
-
UM birding program can help stroke survivors with aphasia
United Kingdom